Gyre Therapeutics
GYRE
GYRE
48 hedge funds and large institutions have $23.1M invested in Gyre Therapeutics in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$267K | |
| 2 | +$135K | |
| 3 | +$111K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$107K |
| 5 |
Jane Street
New York
|
+$96.7K |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$481K | |
| 3 | -$264K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$202K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$201K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
51
Aster Capital Management
Dubai,
United Arab Emirates
| – |
|
|||
52
Raymond James Financial
St Petersburg,
Florida
| – |
|
|||
|
GI
53
GAMMA Investing
Foster City,
California
| – |
|
|||
|
RA
54
Rise Advisors
Rochester,
New York
| – |
|